e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
May 1, 2007
Date of Report (Date of Earliest Event Reported)
BENTLEY PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or Other Jurisdiction of Incorporation)
     
1-10581
(Commission File Number) 		  59-1513162
(I.R.S. Employer Identification No.)
     
Bentley Park
2 Holland Way
Exeter, New Hampshire
(Address of Principal Executive Offices) 		 

03833
(Zip Code)
(603) 658-6100
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 2.02.   Results of Operations and Financial Condition.
Item 9.01.   Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
Ex-99.1 Press release dated May 1, 2007

Table of Contents

 
BENTLEY PHARMACEUTICALS, INC.
Item 2.02.   Results of Operations and Financial Condition.
On May 1, 2007, Bentley Pharmaceuticals, Inc. issued a press release announcing financial results for the three months ended March 31, 2007. A copy of the press release is furnished herewith as Exhibit 99.1.
Item 9.01.   Financial Statements and Exhibits.
         
(c)
  Exhibits    
 
        
 
  99.1   Earnings press release for the three months ended March 31, 2007 dated May 1, 2007.

 

Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
     
     Date: May 1, 2007  By:   /s/ Richard P. Lindsay    
    Richard P. Lindsay   
    Vice President and Chief Financial Officer   

 

Table of Contents

         
 
BENTLEY PHARMACEUTICALS, INC.
EXHIBIT INDEX
     
Exhibit
Number
 
Description of Exhibit
 
    
99.1
  Earnings press release for the three months ended March 31, 2007 dated May 1, 2007.